Melanoma: Updates from Brisbane, Australia The latest data in melanoma reported at the joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma

Access Activity

Overview / Abstract:

Roxana S. Dronca, MD, and Lisa A. Kottschade, APRN, MSN, CNP, offer their expert insights into recent data on advanced melanoma presented at a joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research. Listen to what these experts have to say about combination therapy in the adjuvant setting for metastatic melanoma, real-world utilization of checkpoint inhibitor therapy, sequencing options for BRAF +/- MEK Inhibition following immunotherapy, and the management of rheumatological immune-related adverse events following treatment with checkpoint inhibitors.
CONTENT AREAS
• Combination checkpoint inhibitor therapy
• Utilization of pembrolizumab
• Sequencing options
• Management of de novo rheumatological toxicity

Expiration

Feb 28, 2019

Discipline(s)

Physician CME

Format

Webinar / Webcast / Video

Credits / Hours

1.5 AMA PRA Category 1 Credit(s)™.

Accreditation

ACCME

Presenters / Authors / Faculty

Roxana S. Dronca, MD
Medical Oncologist, Associate Professor of Oncology
Chair of Hematology Oncology
Mayo Clinic, Jacksonville, Florida

Lisa Kottschade, APRN, MSN, CNP
Nurse Practitioner- Melanoma
Associate Professor of Oncology
Chief Operations Officer- Midwest Melanoma Partnership
Mayo Clinic, Rochester, Minnesota

Activity Specialities / Related Topics

Dermatology, Oncology / Cancer / Radiation Therapy

Sponsors / Supporters / Grant Providers

This activity is supported by an independent educational grant from Merck Sharp & Dohme Corp.

Keywords / Search Terms

Annenberg Center for Health Sciences at Eisenhower Melanoma de novo checkpoint inhibitor therapy Sequencing Options Utilization of pembrolizumab 9th World Congress of Melanoma 14th International Congress of the Society for Melanoma Research Free CE CME

Access Activity

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.